Previous Page  33 / 53 Next Page
Information
Show Menu
Previous Page 33 / 53 Next Page
Page Background

Medchem & Toxicology 2018

Page 77

Journal of Organic & Inorganic Chemistry

ISSN: 2472-1123

A n n u a l C o n g r e s s o n

Medicinal Chemistry,

Pharmacology and toxicology

J u l y 3 0 - 3 1 , 2 0 1 8

Am s t e r d a m , N e t h e r l a n d s

M

anganese (Mn) is a trace metal required for normal physiological processes in humans. Mn levels are tightly regulated, as

high levels of Mn results in accumulation in the brain and cause a neurological disease known as manganism. Manganism

shares many similarities with Parkinson’s disease (PD), both at the physiological level and the cellular level. Exposure to high

Mn-containing environments increases the risk of developing manganism. Homozygous mutations in

SLC30A10

cause familial

Parkinsonism associated with manganese (Mn) retention. We recently identified SLC30A10 to be a cell surface-localized Mn

efflux transporter and demonstrated that Parkinsonism causing mutations block its intracellular trafficking and efflux function.

In C. elegans, SLC30A10 over-expression protected against Mn-induced lethality and dopaminergic neurotoxicity, consistent with

results in mammalian systems. SLC30A10 expression did not protect worms against ZnSO

4

toxicity, suggesting that SLC30A10

does not mediate Zn export in

C. elegans.

Michael.Aschner@einstein.yu.edu

Manganese-induced neurotoxicity: lessons

from worms to human neonates

Michael Aschner

Albert Einstein College of Medicine, New York, USA

J Org Inorg Chem 2018, Volume 4

DOI: 10.21767/2472-1123-C3-009